MTST (MetaStat) Current Accrued Expense: $0.47 Mil (As of Feb. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MetaStat Current Accrued Expense?

MetaStat MTST Current Accrued Expense is $0.47 Mil as of Feb. 2018.

MetaStat's Current Accrued Expense for the quarter that ended in Feb. 2018 was $0.47 Mil.

MetaStat's quarterly Current Accrued Expense increased from Aug. 2017 ($0.27 Mil) to Nov. 2017 ($0.44 Mil) and increased from Nov. 2017 ($0.44 Mil) to Feb. 2018 ($0.47 Mil).

MetaStat's annual Current Accrued Expense declined from Feb. 2016 ($0.27 Mil) to Feb. 2017 ($0.20 Mil) but then increased from Feb. 2017 ($0.20 Mil) to Feb. 2018 ($0.47 Mil).

MetaStat Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for MetaStat's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat Current Accrued Expense Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.01 0.27 0.20 0.47

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.29 0.27 0.44 0.47

MetaStat Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.47 Mil mean?
MetaStat (MTST) has a Current Accrued Expense of $0.47 Mil as of Feb. 2018. Current Accrued Expense records the total amount of accrued expenses. View historical data on MetaStat and its competitors.
Is MetaStat's Current Accrued Expense too high?
MetaStat's current Current Accrued Expense is $0.47 Mil.
How does MetaStat's Current Accrued Expense compare to OBMP and NSPX?
MetaStat's Current Accrued Expense of $0.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on MetaStat and its competitors. MetaStat's current Current Accrued Expense is $0.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Current Accrued Expense of $0.47 Mil. The current Current Accrued Expense is $0.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For MetaStat (MTST), the current Current Accrued Expense is $0.47 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.